首页 > 最新文献

Current Health Sciences Journal最新文献

英文 中文
The Influence of the Inflammatory Bowel Diseases on the Perceived Stress and Quality of Life in a Sample of the South-Western Romanian Population. 炎症性肠病对罗马尼亚西南部人群感知压力和生活质量的影响
Pub Date : 2022-01-01 Epub Date: 2022-03-31 DOI: 10.12865/CHSJ.48.01.01
Denisa-Elena Popa, Mihail-Cristian Pîrlog, Dragoş-Ovidiu Alexandru, Dan-Ionuţ Gheonea

Background: Inflammatory bowel diseases (IBD) represent a category of chronic diseases of gastrointestinal tract with a long-term evolution which includes flares and periods of remission. The aim of the study is to identify and quantify the relationship between IBD status, perceived stress, coping mechanisms, and patients QOL.

Methods: Cross-sectional study on two samples consisting of 70 IBD patients monitored in the Gastroenterology Department of the Emergency Clinical County Hospital Craiova, Romania, respectively 70 healthy volunteers. Collected data include socio-demographic details, personal and familial medical history, clinical status, presumed risk factors, perceived stress (Perceived Stress Scale-PSS), coping strategies (COPE questionnaire) and Health-Related Quality of Life (HRQOL-SF-36 scale).

Results: Perceived stress was considerably higher on IBD subjects (p<0.0001). The assessment of HRQOL has shown that patients had the best perception over their physical and emotional domains of SF-36 (p<0.0001), while the most often coping mechanisms used are those from the problem-focused category.

Conclusions: There is a significant relationship between increased activity of IBD and higher level of stress, that led to the development of problem-focused coping strategies. We did not find a strong correlation between lower HRQOL levels and the items considered as potential risk factors.

背景:炎症性肠病(IBD)是一类长期发展的胃肠道慢性疾病,包括发作期和缓解期。本研究的目的是确定和量化IBD状态、感知压力、应对机制和患者生活质量之间的关系。方法:对罗马尼亚克拉约瓦县急诊临床医院消化内科监测的70例IBD患者和70名健康志愿者进行横断面研究。收集的数据包括社会人口学细节、个人和家族病史、临床状况、假定的危险因素、感知压力(感知压力量表- pss)、应对策略(COPE问卷)和健康相关生活质量(HRQOL-SF-36量表)。结果:IBD受试者的感知压力明显更高(结论:IBD活动增加与压力水平升高之间存在显著关系,从而导致以问题为中心的应对策略的发展。我们没有发现较低的HRQOL水平与被认为是潜在危险因素的项目之间有很强的相关性。
{"title":"The Influence of the Inflammatory Bowel Diseases on the Perceived Stress and Quality of Life in a Sample of the South-Western Romanian Population.","authors":"Denisa-Elena Popa,&nbsp;Mihail-Cristian Pîrlog,&nbsp;Dragoş-Ovidiu Alexandru,&nbsp;Dan-Ionuţ Gheonea","doi":"10.12865/CHSJ.48.01.01","DOIUrl":"https://doi.org/10.12865/CHSJ.48.01.01","url":null,"abstract":"<p><strong>Background: </strong>Inflammatory bowel diseases (IBD) represent a category of chronic diseases of gastrointestinal tract with a long-term evolution which includes flares and periods of remission. The aim of the study is to identify and quantify the relationship between IBD status, perceived stress, coping mechanisms, and patients QOL.</p><p><strong>Methods: </strong>Cross-sectional study on two samples consisting of 70 IBD patients monitored in the Gastroenterology Department of the Emergency Clinical County Hospital Craiova, Romania, respectively 70 healthy volunteers. Collected data include socio-demographic details, personal and familial medical history, clinical status, presumed risk factors, perceived stress (Perceived Stress Scale-PSS), coping strategies (COPE questionnaire) and Health-Related Quality of Life (HRQOL-SF-36 scale).</p><p><strong>Results: </strong>Perceived stress was considerably higher on IBD subjects (p<0.0001). The assessment of HRQOL has shown that patients had the best perception over their physical and emotional domains of SF-36 (p<0.0001), while the most often coping mechanisms used are those from the problem-focused category.</p><p><strong>Conclusions: </strong>There is a significant relationship between increased activity of IBD and higher level of stress, that led to the development of problem-focused coping strategies. We did not find a strong correlation between lower HRQOL levels and the items considered as potential risk factors.</p>","PeriodicalId":10938,"journal":{"name":"Current Health Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289598/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40573900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aspects of Humoral Immunity after Vaccination with Bnt162b2: A Small Study. 接种Bnt162b2后体液免疫方面:一项小型研究
Pub Date : 2022-01-01 Epub Date: 2022-03-31 DOI: 10.12865/CHSJ.48.01.03
Lucian-Ion Giubelan, Florentina Dumitrescu, Livia Dragonu, Andreea Cristina Stoian, Cristina Ilie, Ilona Stanciu

Starting from December 2020, vaccination against COVID-19 became available in Romania. There are a lot of uncertainties regarding the kinetics of immunity and its persistance over time. This is a small prospective study developed between January-September 2021 in the Infectious Diseases Clinic from Craiova and comprising 61 subjects immunised with BNT162b2 (Comirnaty). We have found that after two doses of vaccine there is a strong humoral response, but the immunity lowers six months later. Subjects with a diagnosis of COVID-19, previously or in between the two doses, have had the most significant immunological response, but, also, the sharpest decline in antibody titer. The immune response seems to be the same, regardless the gender of the subjects. There are a variety of responses at the individual level, but overall vaccine effectiveness is 96.72% two weeks following immunisation and 88.52% after six months; however for those who have been in contact with the virus, they all had an antibody titer well above the laboratory limit.

从2020年12月开始,罗马尼亚开始接种COVID-19疫苗。关于免疫的动力学及其随时间的持续存在很多不确定性。这是2021年1月至9月在克拉约瓦传染病诊所开展的一项小型前瞻性研究,包括61名接种了BNT162b2 (Comirnaty)的受试者。我们发现,接种两剂疫苗后会产生强烈的体液反应,但6个月后免疫力会下降。诊断为COVID-19的受试者,在之前或在两次剂量之间,有最显著的免疫反应,但抗体滴度下降也最急剧。无论受试者的性别如何,免疫反应似乎都是一样的。在个体层面上有各种各样的反应,但总体疫苗效力在免疫后两周为96.72%,六个月后为88.52%;然而,那些与病毒有过接触的人,他们的抗体滴度都远远高于实验室的限制。
{"title":"Aspects of Humoral Immunity after Vaccination with Bnt162b2: A Small Study.","authors":"Lucian-Ion Giubelan,&nbsp;Florentina Dumitrescu,&nbsp;Livia Dragonu,&nbsp;Andreea Cristina Stoian,&nbsp;Cristina Ilie,&nbsp;Ilona Stanciu","doi":"10.12865/CHSJ.48.01.03","DOIUrl":"https://doi.org/10.12865/CHSJ.48.01.03","url":null,"abstract":"<p><p>Starting from December 2020, vaccination against COVID-19 became available in Romania. There are a lot of uncertainties regarding the kinetics of immunity and its persistance over time. This is a small prospective study developed between January-September 2021 in the Infectious Diseases Clinic from Craiova and comprising 61 subjects immunised with BNT162b2 (Comirnaty). We have found that after two doses of vaccine there is a strong humoral response, but the immunity lowers six months later. Subjects with a diagnosis of COVID-19, previously or in between the two doses, have had the most significant immunological response, but, also, the sharpest decline in antibody titer. The immune response seems to be the same, regardless the gender of the subjects. There are a variety of responses at the individual level, but overall vaccine effectiveness is 96.72% two weeks following immunisation and 88.52% after six months; however for those who have been in contact with the virus, they all had an antibody titer well above the laboratory limit.</p>","PeriodicalId":10938,"journal":{"name":"Current Health Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289581/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40590915","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accuracy of Endoscopic Ultrasonography for Gastric Cancer Staging. 内镜超声检查对胃癌分期的准确性。
Pub Date : 2022-01-01 Epub Date: 2022-03-31 DOI: 10.12865/CHSJ.48.01.13
Victor Mihai Sacerdotianu, Bogdan Silviu Ungureanu, Sevastita Iordache, Maria Monalisa Filip, Daniel Pirici, Ilona Mihaela Liliac, Adrian Saftoiu

Gastric cancer remains a health problem, with treatment indications varying with the TNM stage. We aimed in this study to highlight the role of EUS in GC patients and also to calculate the accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of EUS for T and N staging in our group of patients with this disease. In this study, we included 41 GC patients, and individual values for every T stage accuracy, sensitivity, specificity, PPV, NPV, correct staging, understaging, and overstaging were calculated. EUS overall accuracy for T staging was 58.53%, with the highest sensitivity reached for the T4 stage, 95.83%. For N+vs. N-staging, EUS accuracy was 68.29%, with a sensitivity of 75% and a specificity of 44.44%. The positive and negative predicted values for the presence or absence of nodal disease were 82.75%, respectively 33.33%. In conclusion, this study confirmed the importance of EUS for the assessment of GC T and N stage and highlighted the role of this tool in the detection of liver micrometastasis unrevealed by other imaging techniques like abdominal ultrasound or MSCT.

胃癌仍然是一个健康问题,治疗指征随TNM分期而异。在本研究中,我们旨在强调EUS在胃癌患者中的作用,并计算EUS对本组患者T和N分期的准确性、敏感性、特异性、阳性预测值(PPV)和阴性预测值(NPV)。在这项研究中,我们纳入了41例胃癌患者,并计算了每个T分期的准确性、敏感性、特异性、PPV、NPV、正确分期、分期不足和分期过度的个体值。EUS对T分期的总体准确率为58.53%,其中对T4分期的灵敏度最高,为95.83%。N + vs。n分期时,EUS的准确率为68.29%,敏感性为75%,特异性为44.44%。阳性预测值为82.75%,阴性预测值为33.33%。总之,本研究证实了EUS对GC T和N期评估的重要性,并强调了该工具在腹部超声或MSCT等其他成像技术未发现的肝脏微转移检测中的作用。
{"title":"Accuracy of Endoscopic Ultrasonography for Gastric Cancer Staging.","authors":"Victor Mihai Sacerdotianu,&nbsp;Bogdan Silviu Ungureanu,&nbsp;Sevastita Iordache,&nbsp;Maria Monalisa Filip,&nbsp;Daniel Pirici,&nbsp;Ilona Mihaela Liliac,&nbsp;Adrian Saftoiu","doi":"10.12865/CHSJ.48.01.13","DOIUrl":"https://doi.org/10.12865/CHSJ.48.01.13","url":null,"abstract":"<p><p>Gastric cancer remains a health problem, with treatment indications varying with the TNM stage. We aimed in this study to highlight the role of EUS in GC patients and also to calculate the accuracy, sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) of EUS for T and N staging in our group of patients with this disease. In this study, we included 41 GC patients, and individual values for every T stage accuracy, sensitivity, specificity, PPV, NPV, correct staging, understaging, and overstaging were calculated. EUS overall accuracy for T staging was 58.53%, with the highest sensitivity reached for the T4 stage, 95.83%. For N+vs. N-staging, EUS accuracy was 68.29%, with a sensitivity of 75% and a specificity of 44.44%. The positive and negative predicted values for the presence or absence of nodal disease were 82.75%, respectively 33.33%. In conclusion, this study confirmed the importance of EUS for the assessment of GC T and N stage and highlighted the role of this tool in the detection of liver micrometastasis unrevealed by other imaging techniques like abdominal ultrasound or MSCT.</p>","PeriodicalId":10938,"journal":{"name":"Current Health Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9289590/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40574951","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Colorectal Cancer in County Durham-England a Clinical and Statistical Study. 英国达勒姆郡结直肠癌的临床与统计研究。
Pub Date : 2021-07-01 Epub Date: 2021-09-30 DOI: 10.12865/CHSJ.47.03.02
Daniel Sorin Ilie, Mircea-Sebastian Şerbanescu, Nina Ionovici, Cristina Jana Busuioc, Laurenţiu Mogoantă

Colorectal cancer is one of the most frequently occurring malignancies which associates increasing mortality and morbidity rates. According to data provided by the World Health Organization, colorectal cancer deaths account for approximately 13% of all cancer fatalities. The carcinogenesis of this type of malignancy is a very complex process characterized by various molecular changes which in turn are influenced by factors likes sex, diet, intestinal microbiota, exposure to environmental factors, hosts' immune response and also genetic factors. Our study looked at a total number of 1024 patients, which were all diagnosed with colorectal cancer in a hospital in the north of England, a country that is known for both a high prevalence of this type of cancer but also its robust screening programmers. In our analyses, we concluded that this type of malignancies affected mostly males, aged between 60 and 80. The most commonly affected regions were the rectum, the sigmoid colon and also the cecum. The majority of colorectal cancers (51%) were diagnosed by GPs (general practitioners) or other medical specialties; 43.55% of all cases presented as surgical emergencies and 5.47% were diagnosed through national screening programs. Majority of tumors were diagnosed in late stages, mainly T3 and T4 whilst in was observed that rectal cancers were mainly diagnosed in T2 and T3 stages.

结直肠癌是最常见的恶性肿瘤之一,其死亡率和发病率都在不断上升。根据世界卫生组织提供的数据,结直肠癌死亡人数约占所有癌症死亡人数的13%。这类恶性肿瘤的癌变是一个非常复杂的过程,其特征是各种分子变化,而这些分子变化又受性别、饮食、肠道菌群、暴露环境因素、宿主免疫反应以及遗传因素等因素的影响。我们的研究调查了1024名患者,他们都在英格兰北部的一家医院被诊断出患有结肠直肠癌,这个国家以这种癌症的高患病率而闻名,同时也以其强大的筛查程序而闻名。在我们的分析中,我们得出结论,这种类型的恶性肿瘤主要影响60至80岁的男性。最常见的受累部位是直肠、乙状结肠和盲肠。大多数结直肠癌(51%)是由全科医生或其他医学专业诊断的;43.55%的病例为外科急诊,5.47%的病例是通过国家筛查项目诊断出来的。大多数肿瘤诊断为晚期,以T3和T4期为主,而直肠癌主要诊断为T2和T3期。
{"title":"Colorectal Cancer in County Durham-England a Clinical and Statistical Study.","authors":"Daniel Sorin Ilie,&nbsp;Mircea-Sebastian Şerbanescu,&nbsp;Nina Ionovici,&nbsp;Cristina Jana Busuioc,&nbsp;Laurenţiu Mogoantă","doi":"10.12865/CHSJ.47.03.02","DOIUrl":"https://doi.org/10.12865/CHSJ.47.03.02","url":null,"abstract":"<p><p>Colorectal cancer is one of the most frequently occurring malignancies which associates increasing mortality and morbidity rates. According to data provided by the World Health Organization, colorectal cancer deaths account for approximately 13% of all cancer fatalities. The carcinogenesis of this type of malignancy is a very complex process characterized by various molecular changes which in turn are influenced by factors likes sex, diet, intestinal microbiota, exposure to environmental factors, hosts' immune response and also genetic factors. Our study looked at a total number of 1024 patients, which were all diagnosed with colorectal cancer in a hospital in the north of England, a country that is known for both a high prevalence of this type of cancer but also its robust screening programmers. In our analyses, we concluded that this type of malignancies affected mostly males, aged between 60 and 80. The most commonly affected regions were the rectum, the sigmoid colon and also the cecum. The majority of colorectal cancers (51%) were diagnosed by GPs (general practitioners) or other medical specialties; 43.55% of all cases presented as surgical emergencies and 5.47% were diagnosed through national screening programs. Majority of tumors were diagnosed in late stages, mainly T3 and T4 whilst in was observed that rectal cancers were mainly diagnosed in T2 and T3 stages.</p>","PeriodicalId":10938,"journal":{"name":"Current Health Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679160/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39677494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hip Joint Abnormalities During Midstance in Osteoarthritic Patients. 骨关节炎患者站立时髋关节异常。
Pub Date : 2021-07-01 Epub Date: 2021-09-30 DOI: 10.12865/CHSJ.47.03.05
Carmen Stătescu, Bogdan-Ion Gavrilă, Andrei Deaconu, Rodica-Magdalena Trăistaru, Tudor-Adrian Bălşeanu

Osteoarthritis is one of the most debilitating diseases in Europe affecting the lower limb joints, especially the hip and knee, having a bad influence on gait in the long run as well. Rehabilitation physicians use gait in order for the whole body to be seen in ensemble, and through midstance as moment of gait to also take predilection to falls into consideration. Goniometry is the quantifiable measure of a rehabilitation treatment by measuring the range of motion of each treated joint and studied during time. The patients that volunteered to be part of this study have been divided into four groups, depending on the level of osteoarthritis present at the lower limb joints: hip, knee, both hip and knee osteoarthritis or control group with no osteoarthritis, have been asked to walk for a few times and the video recordings were uploaded into the Angles App where we measured the lower limb joint angles during midstance. Patients with knee osteoarthritis present a more extended hip on both dominant and non-dominant sides compared to the ones with hip osteoarthritis, hip and knee osteoarthritis or control group. The results can be explained through the body's kinematic chains that link the knee and hip, hip and pelvis during the midstance phase in the sagittal plane. A physician can use a video goniometry app in order for him to thoroughly evaluate an osteoarthritic patient as well as follow him or her during the entire course of treatment.

骨关节炎是欧洲最使人衰弱的疾病之一,影响下肢关节,特别是髋关节和膝关节,从长远来看对步态也有不良影响。康复医生使用步态是为了使全身整体可见,而通过中步作为步态的时刻也要考虑到偏好。角度测量是一种可量化的康复治疗方法,通过测量每个治疗关节的活动范围,并在一段时间内进行研究。自愿参加这项研究的患者根据下肢关节骨关节炎的程度被分为四组:髋关节,膝关节,髋关节和膝关节骨关节炎或无骨关节炎的对照组,他们被要求行走几次,录像被上传到angle应用程序中,我们在那里测量了站立时下肢关节的角度。与髋关节骨性关节炎、髋关节和膝关节骨性关节炎或对照组相比,膝关节骨性关节炎患者在优势侧和非优势侧髋关节均表现出更大的延伸。这个结果可以通过身体的运动链来解释,这些运动链连接了膝关节和髋关节,髋关节和骨盆在矢状平面的中间阶段。医生可以使用视频角度测量应用程序来彻底评估骨关节炎患者,并在整个治疗过程中跟踪他或她。
{"title":"Hip Joint Abnormalities During Midstance in Osteoarthritic Patients.","authors":"Carmen Stătescu,&nbsp;Bogdan-Ion Gavrilă,&nbsp;Andrei Deaconu,&nbsp;Rodica-Magdalena Trăistaru,&nbsp;Tudor-Adrian Bălşeanu","doi":"10.12865/CHSJ.47.03.05","DOIUrl":"https://doi.org/10.12865/CHSJ.47.03.05","url":null,"abstract":"<p><p>Osteoarthritis is one of the most debilitating diseases in Europe affecting the lower limb joints, especially the hip and knee, having a bad influence on gait in the long run as well. Rehabilitation physicians use gait in order for the whole body to be seen in ensemble, and through midstance as moment of gait to also take predilection to falls into consideration. Goniometry is the quantifiable measure of a rehabilitation treatment by measuring the range of motion of each treated joint and studied during time. The patients that volunteered to be part of this study have been divided into four groups, depending on the level of osteoarthritis present at the lower limb joints: hip, knee, both hip and knee osteoarthritis or control group with no osteoarthritis, have been asked to walk for a few times and the video recordings were uploaded into the Angles App where we measured the lower limb joint angles during midstance. Patients with knee osteoarthritis present a more extended hip on both dominant and non-dominant sides compared to the ones with hip osteoarthritis, hip and knee osteoarthritis or control group. The results can be explained through the body's kinematic chains that link the knee and hip, hip and pelvis during the midstance phase in the sagittal plane. A physician can use a video goniometry app in order for him to thoroughly evaluate an osteoarthritic patient as well as follow him or her during the entire course of treatment.</p>","PeriodicalId":10938,"journal":{"name":"Current Health Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679151/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39677496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Metabolic Impact of Diabetes Mellitus Type 2 in Hepatitis C Virus Infected Patients. 2型糖尿病对丙型肝炎病毒感染患者代谢的影响
Pub Date : 2021-07-01 Epub Date: 2021-09-30 DOI: 10.12865/CHSJ.47.03.11
Marian-Sorin Popescu, Dan-Mihai Firu, Radu Mitruţ, Dragoş Nicolae Mărgăritescu, Adina-Maria Kamal, Vlad Pădureanu, Paul Mitruţ

Objective: Patients with chronic hepatitis C are subjected to a greater risk of cardiovascular disease and difficult to control diabetes mellitus type 2 (T2DM) comparatively to people that have never contracted Hepatitis C Virus (HCV). We aimed to investigate the impact of T2DM on HCV patients with the help of Fibromax test results compared to nonT2DM patients, and the metabolic differences between the 2 study groups. Our long term goals are to observe the long term impact of achieving systemic virusologic response (SVR) by means of Direct-Acting antivirals (DAA) between the 2 cohorts.

Research design and methods: We selected a lot of 200 patients with HCV that will undergo interferon-free DAA-based antiviral treatment for HCV and we used the results of the Fibromax Test to compare the biological parameters of T2DM and nonT2DM patients. RESULTS Among patients with T2DM compared to NonT2DM there is a significant correlation on Steatotest, NashTest, GGT, Glycemia, body weight, height and BMI. Test also showed that 15,5% of the test group had elevated glycemia, indicating the probability of developing diabetes in the future.

Conclusions: Our results suggest that HCV patients that also have T2DM are subjected to a combined higher risk of accelerated steatosis development, steatohepatitis, added difficulty in controlling glycemic levels. All these previous elements combined with a prevalence for patients to be overweight have a negative metabolic impact. Eradication of HCV with the help of DAA is important in order to help improving the metabolic impact of diabetes on steatosis, steatohepatitis. An added benefit is better management of glycemic control by decreasing insulin use and eliminating one risk factor of T2DM.

目的:与未感染丙型肝炎病毒(HCV)的人相比,慢性丙型肝炎患者发生心血管疾病的风险更大,2型糖尿病(T2DM)的控制难度更大。我们的目的是通过对比非T2DM患者的Fibromax试验结果,研究T2DM对HCV患者的影响,以及两个研究组之间的代谢差异。我们的长期目标是观察通过直接作用抗病毒药物(DAA)在两个队列之间实现系统病毒反应(SVR)的长期影响。研究设计与方法:我们选取了200多例丙型肝炎患者进行无干扰素dav抗病毒治疗,并利用Fibromax试验结果比较T2DM和非T2DM患者的生物学参数。结果T2DM患者与非T2DM患者相比,脂肪测试、nash测试、GGT、血糖、体重、身高、BMI均有显著相关性。测试还显示,实验组中有15.5%的人血糖升高,这表明未来患糖尿病的可能性很大。结论:我们的研究结果表明,合并T2DM的HCV患者更易发生脂肪变性加速发展、脂肪性肝炎和控制血糖水平的困难。所有这些先前的因素与超重患者的患病率相结合,对代谢产生负面影响。在DAA的帮助下根除HCV对于改善糖尿病对脂肪变性和脂肪性肝炎的代谢影响非常重要。一个额外的好处是通过减少胰岛素使用和消除T2DM的一个危险因素,更好地管理血糖控制。
{"title":"Metabolic Impact of Diabetes Mellitus Type 2 in Hepatitis C Virus Infected Patients.","authors":"Marian-Sorin Popescu,&nbsp;Dan-Mihai Firu,&nbsp;Radu Mitruţ,&nbsp;Dragoş Nicolae Mărgăritescu,&nbsp;Adina-Maria Kamal,&nbsp;Vlad Pădureanu,&nbsp;Paul Mitruţ","doi":"10.12865/CHSJ.47.03.11","DOIUrl":"https://doi.org/10.12865/CHSJ.47.03.11","url":null,"abstract":"<p><strong>Objective: </strong>Patients with chronic hepatitis C are subjected to a greater risk of cardiovascular disease and difficult to control diabetes mellitus type 2 (T2DM) comparatively to people that have never contracted Hepatitis C Virus (HCV). We aimed to investigate the impact of T2DM on HCV patients with the help of Fibromax test results compared to nonT2DM patients, and the metabolic differences between the 2 study groups. Our long term goals are to observe the long term impact of achieving systemic virusologic response (SVR) by means of Direct-Acting antivirals (DAA) between the 2 cohorts.</p><p><strong>Research design and methods: </strong>We selected a lot of 200 patients with HCV that will undergo interferon-free DAA-based antiviral treatment for HCV and we used the results of the Fibromax Test to compare the biological parameters of T2DM and nonT2DM patients. RESULTS Among patients with T2DM compared to NonT2DM there is a significant correlation on Steatotest, NashTest, GGT, Glycemia, body weight, height and BMI. Test also showed that 15,5% of the test group had elevated glycemia, indicating the probability of developing diabetes in the future.</p><p><strong>Conclusions: </strong>Our results suggest that HCV patients that also have T2DM are subjected to a combined higher risk of accelerated steatosis development, steatohepatitis, added difficulty in controlling glycemic levels. All these previous elements combined with a prevalence for patients to be overweight have a negative metabolic impact. Eradication of HCV with the help of DAA is important in order to help improving the metabolic impact of diabetes on steatosis, steatohepatitis. An added benefit is better management of glycemic control by decreasing insulin use and eliminating one risk factor of T2DM.</p>","PeriodicalId":10938,"journal":{"name":"Current Health Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679152/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39914180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Potential of Helianthin Loaded Into Magnetic Nanoparticles to Induce Cytotoxicity in Glioblastoma Cells. 向日葵素负载磁性纳米颗粒诱导胶质母细胞瘤细胞毒性的潜力。
Pub Date : 2021-07-01 Epub Date: 2021-09-30 DOI: 10.12865/CHSJ.47.03.12
Alexandra Costachi, Cătălina Elena Cioc, Sandra Alice Buteică, Daniela Elise Tache, Ştefan-Alexandru Artene, Ani-Simona Sevastre, Oana Alexandru, Ligia Gabriela Tătăranu, Ştefana Oana Popescu, Anica Dricu

The central nervous system tumors are the most common solid tumors in adults.. Unlike other types of cancers, brain cancer is much difficult to treat because of the blood-brain barrier (BBB) that prevents drug substances from crossing it and accessing the brain. Different types of methods to overcome BBB have been used in vivo and in vitro, of which the use of nanoparticle-mediated delivery of therapeutic drugs is particularly promising. In the present study, we used iron oxide magnetic nanoparticles (NPs) as carrier system for helianthin (He/NPs) to treat cancer cells derived from glioblastoma. An early passage cell cultures (GB1B), established in our laboratory from tissue obtained from a patient diagnosed with glioblastoma, was used. The cells were treated with different concentrations of NPs or HeNPs and then cell proliferation was measured at 24, 48 and 72 hours. Our results showed that the treatment with NPs was well tolerated by glioblastoma cells, the viability of the cells increased very slightly after the treatment. Furthermore, we demonstrated that helianthin loaded Fe3O4 magnetic nanoparticles induced cytotoxicity in human glioblastoma cells. The treatment with HeNPs induced dose and time dependent.

中枢神经系统肿瘤是成人最常见的实体肿瘤。与其他类型的癌症不同,脑癌很难治疗,因为血脑屏障(BBB)阻止药物穿过它进入大脑。不同类型的克服血脑屏障的方法已经在体内和体外使用,其中使用纳米颗粒介导的治疗药物递送特别有希望。在本研究中,我们使用氧化铁磁性纳米颗粒(NPs)作为helianthin (He/NPs)的载体系统来治疗来自胶质母细胞瘤的癌细胞。使用我们实验室从诊断为胶质母细胞瘤的患者的组织中建立的早期传代细胞培养(GB1B)。分别用不同浓度的NPs和HeNPs处理细胞,分别在24、48和72 h检测细胞增殖情况。我们的结果表明,NPs对胶质母细胞瘤细胞具有良好的耐受性,治疗后细胞的活力略有增加。此外,我们证明了负载Fe3O4磁性纳米颗粒的向日葵素对人胶质母细胞瘤细胞具有细胞毒性。HeNPs诱导的剂量和时间依赖性。
{"title":"The Potential of Helianthin Loaded Into Magnetic Nanoparticles to Induce Cytotoxicity in Glioblastoma Cells.","authors":"Alexandra Costachi,&nbsp;Cătălina Elena Cioc,&nbsp;Sandra Alice Buteică,&nbsp;Daniela Elise Tache,&nbsp;Ştefan-Alexandru Artene,&nbsp;Ani-Simona Sevastre,&nbsp;Oana Alexandru,&nbsp;Ligia Gabriela Tătăranu,&nbsp;Ştefana Oana Popescu,&nbsp;Anica Dricu","doi":"10.12865/CHSJ.47.03.12","DOIUrl":"https://doi.org/10.12865/CHSJ.47.03.12","url":null,"abstract":"<p><p>The central nervous system tumors are the most common solid tumors in adults.. Unlike other types of cancers, brain cancer is much difficult to treat because of the blood-brain barrier (BBB) that prevents drug substances from crossing it and accessing the brain. Different types of methods to overcome BBB have been used in vivo and in vitro, of which the use of nanoparticle-mediated delivery of therapeutic drugs is particularly promising. In the present study, we used iron oxide magnetic nanoparticles (NPs) as carrier system for helianthin (He/NPs) to treat cancer cells derived from glioblastoma. An early passage cell cultures (GB1B), established in our laboratory from tissue obtained from a patient diagnosed with glioblastoma, was used. The cells were treated with different concentrations of NPs or HeNPs and then cell proliferation was measured at 24, 48 and 72 hours. Our results showed that the treatment with NPs was well tolerated by glioblastoma cells, the viability of the cells increased very slightly after the treatment. Furthermore, we demonstrated that helianthin loaded Fe3O4 magnetic nanoparticles induced cytotoxicity in human glioblastoma cells. The treatment with HeNPs induced dose and time dependent.</p>","PeriodicalId":10938,"journal":{"name":"Current Health Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679159/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39914181","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Conservative Management of a Jejuno-Jejunal Intussusception in a Patient with Severe Haemophilia A. 1例严重血友病a患者空肠-空肠肠套叠的保守治疗。
Pub Date : 2021-07-01 Epub Date: 2021-09-30 DOI: 10.12865/CHSJ.47.03.20
Fares Salma, Wakrim Soukaina

A 29-year-old man with severe haemophilia A developed right lower quadrant pain. He was diagnosed with jejuno-jejunal intussusception, and he was managed conservatively with an infusion of plasmatic factor VIII, resulting in resolution of symptoms, and reduction of the jejuno-jejunal intussusception, and complete regression of hematoma. This case highlights a rare clinical manifestation in patients with haemophilia, and also indicates the effectiveness of factor VIII instead of exploratory surgery for intramural hematoma.

一名患有严重血友病A的29岁男子出现右下腹疼痛。他被诊断为空肠-空肠肠套叠,并通过输注血浆因子VIII进行保守治疗,症状得到缓解,空肠-空肠套叠减少,血肿完全消退。该病例突出了血友病患者的罕见临床表现,也表明了因子VIII代替壁内血肿探查手术的有效性。
{"title":"Conservative Management of a Jejuno-Jejunal Intussusception in a Patient with Severe Haemophilia A.","authors":"Fares Salma,&nbsp;Wakrim Soukaina","doi":"10.12865/CHSJ.47.03.20","DOIUrl":"10.12865/CHSJ.47.03.20","url":null,"abstract":"<p><p>A 29-year-old man with severe haemophilia A developed right lower quadrant pain. He was diagnosed with jejuno-jejunal intussusception, and he was managed conservatively with an infusion of plasmatic factor VIII, resulting in resolution of symptoms, and reduction of the jejuno-jejunal intussusception, and complete regression of hematoma. This case highlights a rare clinical manifestation in patients with haemophilia, and also indicates the effectiveness of factor VIII instead of exploratory surgery for intramural hematoma.</p>","PeriodicalId":10938,"journal":{"name":"Current Health Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679154/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39801096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Hepatitis C Virus Infection and the New Therapeutical Approach. 丙型肝炎病毒感染和新的治疗方法。
Pub Date : 2021-07-01 Epub Date: 2021-09-30 DOI: 10.12865/CHSJ.47.03.04
Claudia Monica Danilescu, Mihail Cristian Pîrlog, Ion Rogoveanu

Hepatitis C virus represents one of the most important public health problems nowadays. Several epidemiological studies have shown a continuous increasing rate of prevalence and incidence with severe consequences in terms of mortality. During the last decades, the treatment of the liver infection has evolved, and now there are available new therapies with better side-effect' profiles and bigger efficiency. The needs for more therapeutically efficacy also stand behind the numerous comorbidities associated to the liver disease, and also for assuring better quality of life for patients and their families.

丙型肝炎病毒是当今最重要的公共卫生问题之一。几项流行病学研究表明,流行率和发病率持续上升,在死亡率方面造成严重后果。在过去的几十年里,肝脏感染的治疗已经发生了变化,现在有了副作用更小、效率更高的新疗法。对更多治疗效果的需求也支持与肝脏疾病相关的众多合并症,以及确保患者及其家属更好的生活质量。
{"title":"Hepatitis C Virus Infection and the New Therapeutical Approach.","authors":"Claudia Monica Danilescu,&nbsp;Mihail Cristian Pîrlog,&nbsp;Ion Rogoveanu","doi":"10.12865/CHSJ.47.03.04","DOIUrl":"https://doi.org/10.12865/CHSJ.47.03.04","url":null,"abstract":"<p><p>Hepatitis C virus represents one of the most important public health problems nowadays. Several epidemiological studies have shown a continuous increasing rate of prevalence and incidence with severe consequences in terms of mortality. During the last decades, the treatment of the liver infection has evolved, and now there are available new therapies with better side-effect' profiles and bigger efficiency. The needs for more therapeutically efficacy also stand behind the numerous comorbidities associated to the liver disease, and also for assuring better quality of life for patients and their families.</p>","PeriodicalId":10938,"journal":{"name":"Current Health Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679141/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39677495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Macroscopic Changes in Oral Mucosa and Hygiene Indicators in Smokers. 吸烟者口腔黏膜及卫生指标的宏观变化。
Pub Date : 2021-07-01 Epub Date: 2021-09-30 DOI: 10.12865/CHSJ.47.03.08
Gabriel Valeriu Popa, Laurenţiu Mogoantă, Oana Badea

Smoking is the most important factor affecting the oral cavity by components born in the tobacco combustion process and acting directly on the oral mucous membranes, dental arch and indirectly on the teeth support. Recent studies show the tobacco action on the oral cavity, manifestations in the form of gingivitis, bacterial plaque, dental plaque, papillary bleeding at drilling, periodontitis.

Purpose of the study: In this study, we have set out to assess the macroscopic modifications of oral cavity on smokers.

Materials and methods: The participants in the study were divided into two groups, the first group of smokers with a smoking period over 5 years and the control group of nonsmokers. The patients in the two groups underwent a physical examination and an objective clinical examination, the resulting data being compared with the control group.

Results: For the bacterial plaque indicatorin the smoker group there was obtained a mean value of 35.68±12.45, compared to a mean value of 16.32±6.61 for the nonsmoker group, the dental plaque indicatorfor the smoker group had a mean value of 2.24±1.02, higher than the one in the nonsmoker group, namely 0.94±0.68, and for the drilling bleeding indicator we obtained a mean value of 19.54±7.89 in the nonsmoker group, which is lower than that in the smoker group, namely 42.86±14.93.

Conclusions: Smoking is a cause that maintains and aggravates the periodontal disease, including the risk of periodontitis, allowing the aggravation of gingivitis, considered a reversible surface inflammation of the gum mucosa which, by accumulation of dental plaque, the dental plaque accompanied by incorrect oral hygiene, favors the progression to periodontitis.

吸烟是影响口腔的最重要因素,烟草燃烧过程中产生的成分直接作用于口腔粘膜、牙弓,间接作用于牙齿支撑。近年来的研究表明,烟草对口腔的作用,表现为牙龈炎、细菌性牙菌斑、牙菌斑、钻孔时乳头状出血、牙周炎等。研究目的:在这项研究中,我们开始评估吸烟者口腔的宏观改变。材料与方法:将研究对象分为两组,第一组为吸烟时间在5年以上的吸烟者,对照组为不吸烟者。两组患者均进行体格检查和客观临床检查,并与对照组进行比较。结果:吸烟组菌斑指标平均值为35.68±12.45,高于不吸烟组的平均值(16.32±6.61);牙菌斑指标平均值为2.24±1.02,高于不吸烟组的平均值(0.94±0.68);钻出血指标平均值为19.54±7.89,低于不吸烟组的平均值(42.86±14.93)。结论:吸烟是维持和加重牙周病的一个原因,包括牙周炎的风险,允许牙龈炎的恶化,被认为是牙龈粘膜的可逆表面炎症,通过牙菌斑的积累,牙菌斑伴随着不正确的口腔卫生,有利于牙周炎的进展。
{"title":"Macroscopic Changes in Oral Mucosa and Hygiene Indicators in Smokers.","authors":"Gabriel Valeriu Popa,&nbsp;Laurenţiu Mogoantă,&nbsp;Oana Badea","doi":"10.12865/CHSJ.47.03.08","DOIUrl":"https://doi.org/10.12865/CHSJ.47.03.08","url":null,"abstract":"<p><p>Smoking is the most important factor affecting the oral cavity by components born in the tobacco combustion process and acting directly on the oral mucous membranes, dental arch and indirectly on the teeth support. Recent studies show the tobacco action on the oral cavity, manifestations in the form of gingivitis, bacterial plaque, dental plaque, papillary bleeding at drilling, periodontitis.</p><p><strong>Purpose of the study: </strong>In this study, we have set out to assess the macroscopic modifications of oral cavity on smokers.</p><p><strong>Materials and methods: </strong>The participants in the study were divided into two groups, the first group of smokers with a smoking period over 5 years and the control group of nonsmokers. The patients in the two groups underwent a physical examination and an objective clinical examination, the resulting data being compared with the control group.</p><p><strong>Results: </strong>For the bacterial plaque indicatorin the smoker group there was obtained a mean value of 35.68±12.45, compared to a mean value of 16.32±6.61 for the nonsmoker group, the dental plaque indicatorfor the smoker group had a mean value of 2.24±1.02, higher than the one in the nonsmoker group, namely 0.94±0.68, and for the drilling bleeding indicator we obtained a mean value of 19.54±7.89 in the nonsmoker group, which is lower than that in the smoker group, namely 42.86±14.93.</p><p><strong>Conclusions: </strong>Smoking is a cause that maintains and aggravates the periodontal disease, including the risk of periodontitis, allowing the aggravation of gingivitis, considered a reversible surface inflammation of the gum mucosa which, by accumulation of dental plaque, the dental plaque accompanied by incorrect oral hygiene, favors the progression to periodontitis.</p>","PeriodicalId":10938,"journal":{"name":"Current Health Sciences Journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8679161/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39914178","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Health Sciences Journal
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1